FI950144A0 - Lysotsyymidimeeri ja sitä sisältävät koostumukset - Google Patents

Lysotsyymidimeeri ja sitä sisältävät koostumukset

Info

Publication number: FI950144A0
Authority: FI; Finland
Prior art keywords: compositions containing; treatment; lysozyme dimer; tumor necrosis; lysozyme
Prior art date: 1992-07-13

Application number

FI950144A

Other languages

English (en)

Swedish (sv)

Other versions

FI950144L (fi

Inventor

Witold Kiczka

Original Assignee

Nika Health Products Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-13

Filing date

1995-01-12

Publication date

1995-01-12

1995-01-12 Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd

1995-01-12 Publication of FI950144L publication Critical patent/FI950144L/fi

1995-01-12 Publication of FI950144A0 publication Critical patent/FI950144A0/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Hematology (AREA)
Materials Engineering (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Tropical Medicine & Parasitology (AREA)
Microbiology (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Heart & Thoracic Surgery (AREA)
General Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

FI950144A 1992-07-13 1995-01-12 Lysotsyymidimeeri ja sitä sisältävät koostumukset FI950144A0 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PL92295273A PL173978B1 (pl)	1992-07-13	1992-07-13	Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
PCT/EP1993/001841 WO1994001127A1 (en)	1992-07-13	1993-07-13	Lysozyme dimer and compositions containing the same

Publications (2)

Publication Number	Publication Date
FI950144L FI950144L (fi)	1995-01-12
FI950144A0 true FI950144A0 (fi)	1995-01-12

Family

ID=20058087

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI950144A FI950144A0 (fi)	1992-07-13	1995-01-12	Lysotsyymidimeeri ja sitä sisältävät koostumukset

Country Status (31)

Country	Link
US (1)	US6132715A (fi)
EP (1)	EP0651654B1 (fi)
JP (1)	JPH07508744A (fi)
KR (1)	KR100289841B1 (fi)
CN (1)	CN1057937C (fi)
AT (1)	ATE252392T1 (fi)
AU (1)	AU677786B2 (fi)
BG (1)	BG63331B1 (fi)
BR (1)	BR9306722A (fi)
CA (1)	CA2140140A1 (fi)
CZ (1)	CZ286725B6 (fi)
DE (2)	DE651654T1 (fi)
DK (1)	DK0651654T3 (fi)
ES (1)	ES2074037T3 (fi)
FI (1)	FI950144A0 (fi)
GE (1)	GEP20012466B (fi)
GR (1)	GR950300039T1 (fi)
HU (1)	HU218151B (fi)
MX (1)	MX9304197A (fi)
NZ (2)	NZ254135A (fi)
OA (1)	OA10125A (fi)
PL (1)	PL173978B1 (fi)
PT (1)	PT651654E (fi)
RO (1)	RO112580B1 (fi)
RU (1)	RU2145875C1 (fi)
SG (1)	SG52727A1 (fi)
SK (1)	SK282377B6 (fi)
TW (1)	TW259710B (fi)
UA (1)	UA49789C2 (fi)
WO (1)	WO1994001127A1 (fi)
ZA (1)	ZA935046B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6183742B1 (en)	1992-07-13	2001-02-06	Nika Health Products, Limited	Applications of lysozyme dimer
DZ1964A1 (fr) *	1995-01-13	2002-10-15	Nika Health Products Ltd	Nouvelle applications d'un dimère de lysozyme.
EP0793472A4 (en) *	1995-05-30	2000-12-27	Lectin Biopharma Inc	METHOD FOR USING LECTINES FOR AGGLUTINATION AND FOR COLLECTING MENSTRUATION FLUIDS
US6123937A (en) *	1997-03-14	2000-09-26	Nika Health Products, Limited	Applications of lysozyme dimer
ITMI981148A1 (it)	1998-05-22	1999-11-22	Therapicon Srl	Utilizzo di lisozima c modificato per preparare composizioni medicinali per il trattamento di alcune gravi malattie
EP1174147A1 (en) *	2000-06-27	2002-01-23	Nika Health Products Limited	Reversal of antibiotic resistance with lysozyme dimer
US20050244402A1 (en) *	2004-04-30	2005-11-03	Villanueva Julie M	Absorption of pain-causing agents
RU2472467C2 (ru) *	2011-04-13	2013-01-20	Государственное научное учреждение Краснодарский научно-исследовательский ветеринарный институт (ГНУ КНИВИ)	Способ профилактики и лечения гастроэнтеритов, обусловленных бактериозами, у телят
RU2546911C2 (ru) *	2013-04-11	2015-04-10	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Донской государственный аграрный университет"	Способ хранения свинины в охлажденном состоянии
CN105106626A (zh) *	2015-09-30	2015-12-02	成都倍加特生物科技有限公司	一种治疗月经期感染的汤剂药物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR4020M (fi) *	1965-01-29	1966-03-21
FR2215201A1 (en) *	1973-01-24	1974-08-23	Theranol Lab	Broad-spectrum antibiotic compsns. - contg. antibiotic resistant lactic bacilli and enzyme diffusing-agent
JPS5533408A (en) *	1978-08-30	1980-03-08	Eisai Co Ltd	Immunity-increasing agent
JPS5533409A (en) *	1978-08-30	1980-03-08	Eisai Co Ltd	Carcinostatic agent
JPS5543040A (en) *	1978-09-25	1980-03-26	Eisai Co Ltd	Immunity raising agent
US4221794A (en) *	1979-06-21	1980-09-09	Newport Pharmaceuticals International, Inc.	Method of imparting immunomodulating and antiviral activity
US4457919A (en) *	1980-03-14	1984-07-03	Newport Pharmaceutical International, Inc.	Method of imparting immunomodulating, antiviral or antitumor activity
US4510144A (en) *	1981-08-26	1985-04-09	Newport Pharmaceuticals International	Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
US4739046A (en) *	1985-08-19	1988-04-19	Luzio Nicholas R Di	Soluble phosphorylated glucan
US4744984A (en) *	1985-10-08	1988-05-17	Vetrepharm Research, Inc.	Antiviral immunotherapeutic agent and preparation thereof
DE3782958D1 (de) *	1986-02-19	1993-01-21	Imreg Inc	Verfahren und mittel zum pruefen eines immunsystems.
US5200182A (en) *	1988-05-26	1993-04-06	Nika Health Products, Ltd.	Antiviral or antibacterial composition and method of use
DE3817955A1 (de) *	1988-05-27	1989-11-30	Hoechst Ag	Tnf-inhibitor enthaltendes arzneimittel
JP2568447B2 (ja) *	1988-05-31	1997-01-08	ナップ・システムズ・（ユーエスエイ）・インコーポレーテッド	印刷原板を処理するための装置及び方法
WO1991000092A1 (en) *	1989-06-13	1991-01-10	Smithkline Beecham Corporation	Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
SG49871A1 (en) *	1990-01-08	1998-06-15	Nika Health Products Ltd	Method of preparing lysozyme dimers
US5314816A (en) *	1990-01-08	1994-05-24	Nika Health Products Ltd.	Method of preparing lysozyme dimers
CA2088352A1 (en) *	1990-08-03	1992-02-04	Klaus M. Esser	Tnf inhibitors

1992
- 1992-07-13 PL PL92295273A patent/PL173978B1/pl not_active IP Right Cessation
1993
- 1993-07-13 BR BR9306722A patent/BR9306722A/pt not_active Application Discontinuation
- 1993-07-13 SK SK40-95A patent/SK282377B6/sk not_active IP Right Cessation
- 1993-07-13 CN CN93116771A patent/CN1057937C/zh not_active Expired - Fee Related
- 1993-07-13 AT AT93915903T patent/ATE252392T1/de not_active IP Right Cessation
- 1993-07-13 WO PCT/EP1993/001841 patent/WO1994001127A1/en active IP Right Grant
- 1993-07-13 DK DK93915903T patent/DK0651654T3/da active
- 1993-07-13 ES ES93915903T patent/ES2074037T3/es not_active Expired - Lifetime
- 1993-07-13 EP EP93915903A patent/EP0651654B1/en not_active Expired - Lifetime
- 1993-07-13 UA UA95018021A patent/UA49789C2/uk unknown
- 1993-07-13 DE DE0651654T patent/DE651654T1/de active Pending
- 1993-07-13 CZ CZ199585A patent/CZ286725B6/cs not_active IP Right Cessation
- 1993-07-13 AU AU45686/93A patent/AU677786B2/en not_active Ceased
- 1993-07-13 HU HU9500098A patent/HU218151B/hu not_active IP Right Cessation
- 1993-07-13 GE GEAP19932466A patent/GEP20012466B/en unknown
- 1993-07-13 JP JP6502985A patent/JPH07508744A/ja active Pending
- 1993-07-13 NZ NZ254135A patent/NZ254135A/en not_active IP Right Cessation
- 1993-07-13 PT PT93915903T patent/PT651654E/pt unknown
- 1993-07-13 ZA ZA935046A patent/ZA935046B/xx unknown
- 1993-07-13 RU RU95105517A patent/RU2145875C1/ru not_active IP Right Cessation
- 1993-07-13 RO RO95-00041A patent/RO112580B1/ro unknown
- 1993-07-13 SG SG1996008336A patent/SG52727A1/en unknown
- 1993-07-13 DE DE69333258T patent/DE69333258T2/de not_active Expired - Lifetime
- 1993-07-13 MX MX9304197A patent/MX9304197A/es not_active IP Right Cessation
- 1993-07-13 KR KR1019940704649A patent/KR100289841B1/ko not_active IP Right Cessation
- 1993-07-13 CA CA002140140A patent/CA2140140A1/en not_active Abandoned
- 1993-08-03 TW TW082106180A patent/TW259710B/zh active
1994
- 1994-12-22 BG BG99287A patent/BG63331B1/bg unknown
1995
- 1995-01-12 FI FI950144A patent/FI950144A0/fi unknown
- 1995-01-13 OA OA60604A patent/OA10125A/en unknown
- 1995-06-07 US US08/476,561 patent/US6132715A/en not_active Expired - Fee Related
- 1995-07-31 GR GR950300039T patent/GR950300039T1/el unknown
1996
- 1996-09-13 NZ NZ299377A patent/NZ299377A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU9500098D0 (en)	1995-03-28
WO1994001127A1 (en)	1994-01-20
BR9306722A (pt)	1998-12-08
OA10125A (en)	1996-12-18
PT651654E (pt)	2004-03-31
ES2074037T1 (es)	1995-09-01
HU218151B (hu)	2000-06-28
KR100289841B1 (ko)	2001-05-15
CN1057937C (zh)	2000-11-01
BG63331B1 (bg)	2001-10-31
RU2145875C1 (ru)	2000-02-27
PL173978B1 (pl)	1998-05-29
KR950702432A (ko)	1995-07-29
US6132715A (en)	2000-10-17
GEP20012466B (en)	2001-06-25
NZ254135A (en)	1996-11-26
ATE252392T1 (de)	2003-11-15
NZ299377A (en)	2001-02-23
FI950144L (fi)	1995-01-12
CZ8595A3 (en)	1995-09-13
TW259710B (fi)	1995-10-11
SK4095A3 (en)	1995-09-13
RO112580B1 (ro)	1997-11-28
CA2140140A1 (en)	1994-01-20
DE69333258T2 (de)	2004-08-26
PL295273A1 (en)	1994-01-24
DE651654T1 (de)	1996-01-04
EP0651654B1 (en)	2003-10-22
BG99287A (bg)	1995-08-28
DK0651654T3 (da)	2004-02-23
AU677786B2 (en)	1997-05-08
DE69333258D1 (de)	2003-11-27
JPH07508744A (ja)	1995-09-28
ES2074037T3 (es)	2004-07-01
CN1087278A (zh)	1994-06-01
MX9304197A (es)	1994-02-28
CZ286725B6 (en)	2000-06-14
AU4568693A (en)	1994-01-31
HUT70973A (en)	1995-11-28
ZA935046B (en)	1994-02-07
EP0651654A1 (en)	1995-05-10
SG52727A1 (en)	1998-09-28
GR950300039T1 (en)	1995-07-31
UA49789C2 (uk)	2002-10-15
SK282377B6 (sk)	2002-01-07

Publication	Publication Date	Title
FI875533L (fi)	1987-12-16	Insulinpreparat foer non-parenteral dosering.
ATE113213T1 (de)	1994-11-15	Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE69330032D1 (de)	2001-04-19	Therapeutisches kombinationspräparat enthaltend interferon
FI940932A0 (fi)	1994-02-28	Koostumuksia ja menetelmiä haavojen hoitamiseksi
BR9815439A (pt)	2001-10-16	Analgesia contìnua obtida com buprenorphine
ATE157251T1 (de)	1997-09-15	Verwendung von inositoltriphosphat zur behandlung von entzündungen
ATE433756T1 (de)	2009-07-15	Gelierte zusammensetzungen
SE7600284L (sv)	1976-07-16	Terapeutisk insulinberedning.
IT1281188B1 (it)	1998-02-17	Composizione per prevenire e trattare infiammazioni con immunoglobulina a.
FI950144A0 (fi)	1995-01-12	Lysotsyymidimeeri ja sitä sisältävät koostumukset
ES2054098T3 (es)	1994-08-01	Uso de minoxidilo para la curacion de heridas.
ATE220912T1 (de)	2002-08-15	Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
DK578887A (da)	1988-05-06	Antihypertensiva
DK148890D0 (da)	1990-06-19	Farmaceutisk praeparat
SE7708176L (sv)	1978-01-20	Bensamidforeningar
HUP9903679A2 (hu)	2000-04-28	Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
DK277387A (da)	1987-12-01	Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
BG43187A3 (en)	1988-04-15	Method for preparing of auronic derivatives
KR910021244A (ko)	1991-12-20	당뇨병성 괴저 치료제
ATE8966T1 (de)	1984-09-15	Analgetische potenzierung.
KR920019349A (ko)	1992-11-19	불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
ES2033927T3 (es)	1993-04-01	Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.
SE8604587D0 (sv)	1986-10-28	Lekemedelssats for sarlekningsstimulering samt sett att anvenda och tillverka satsen
Bronfenbrenner et al.	1935	Deleterious Effects of Local Application of Staphylococcus Bacteriophage.
ES460319A1 (es)	1978-04-16	Procedimiento para la obtencion de nuevos derivados de qui- noxalina-1,4-dioxido.